Skip to Main Content

Paper Details

Evaluation of an RNAseq-Based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate Cancer.
Cells
0
2021
(prostate) cancer, CD14+, CD2+, Early-Stage Prostate Cancer, PSA, RNA, RNAseq, cancer, circulating immune cells, non-phagocytic CD2+ cells, patients, phagocytic CD14+, prostate cancer, serum prostate-specific antigen, tumor
Author NameAffiliation
Leander Van Neste
Shrikant ManeYale University Center for Genomic Analysis
Philip W KantoffMemorial Sloan Kettering Cancer Center
Philip W KantoffConvergent Therapeutics Inc.
Philip W KantoffMemorial Sloan Kettering Cancer Center
Philip W KantoffConvergent Therapeutics Inc.
  • 1 - 6

Datasets

Release 1.2